EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets

Junxuan Lü, Cheng Jiang, Joseph J Drabick, Monika Joshi, Stuthi Perimbeti

Pharmaceutical Research · 2025

DOI: 10.1007/s11095-024-03809-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2025. Verfasst von Junxuan Lü und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. junxuanlu@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Angelica, Phytochemicals, Plant Extracts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, National Center for Complementary and Integrative Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angelica gigas Nakai (AGN) root is a medicinal herbal widely used in traditional medicine in Korea. AGN root ethanolic extracts have been marketed as dietary supplements in the United States for memory health and pain management. We have recently reviewed the pharmacokinetics (PK) and first-pass hepatic metabolism of ingested AGN supplements in humans for the signature pyranocoumarins decursin (D, C max 1x), decursinol angelate (DA, C max ~ 10x) and their common botanical precursor and hepatic metabolite decursinol (DOH, C max ~ 1000x). Here we update in vivo medicinal activities of AGN and/or its pyranocoumarins and furanocoumarin nodakenin in cancer, pain, memory loss, cerebral ischemia reperfusion stroke, metabolic syndrome and vascular endothelial dysfunctions, anxiety, sleep disorder, epilepsy, inflammatory bowel disease, osteoporosis and osteoarthritis. Given their polypharmacology nature, the pertinent mechanisms of action are likely misrepresented by many cell culture studies that did not consider the drug metabolism knowledge. We report here Rho -associated protein kinases (ROCK1/2) as novel targets for DA and DOH. Combining with published inhibitory activity of DOH on acetylcholinesterase, agonist activity of DOH and antagonist/degrader activity of DA/D on androgen and estrogen receptors, D/DA promoting activity for glutamic acid decarboxylase (GAD)- gamma-aminobutyric acid (GABA) inhibitory axis and inhibition of glutamate dehydrogenase (GDH), monoamine oxidase-A (MAO-A) and transient receptor potential vanilloid 1 (TRPV1), we postulate their contributions to neuro-cognitive, metabolic, oncologic, vascular and other beneficial bioactivities of AGN extracts. A clinical trial is being planned for an AGN extract to manage side effects of androgen deprivation therapy in prostate cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngelicaPhytochemicalsPlant ExtractsAnimalsHumansBenzopyransMedicine, Korean TraditionalPlant RootsButyrates

Stichwörter der Autor:innen

ROCK1/2decursindecursinoldecursinol angelatenodakenin

Substanzen

BenzopyransdecursinPhytochemicalsPlant ExtractsButyrates

Autor:innen und Institutionen

  • Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. junxuanlu@pennstatehealth.psu.edu.
  • Penn State Cancer Institute, Pennsylvania State University, Hershey, PA, 17033, USA. junxuanlu@pennstatehealth.psu.edu.
  • Center for Cannabis and Natural Product Pharmaceutics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. junxuanlu@pennstatehealth.psu.edu.
  • Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
  • Center for Cannabis and Natural Product Pharmaceutics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
  • Penn State Cancer Institute, Pennsylvania State University, Hershey, PA, 17033, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Center for Complementary and Integrative Health

Zitieren

APA

Lü, J., Jiang, C., Drabick, J. J., Joshi, M., & Perimbeti, S. (2025). Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03809-9

Vancouver

Lü J, Jiang C, Drabick JJ, Joshi M, Perimbeti S. Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets. Pharmaceutical Research. 2025. doi:10.1007/s11095-024-03809-9

BibTeX
@article{L2025,
  author = {Lü, Junxuan and Jiang, Cheng and Drabick, Joseph J and Joshi, Monika and Perimbeti, Stuthi},
  title = {Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets},
  journal = {Pharmaceutical Research},
  year = {2025},
  doi = {10.1007/s11095-024-03809-9}
}
Kostenlos starten →